1. Home
  2. Funding
  3. Continuation Funding
  4. Accelerating Cancer Screening

Accelerating Cancer Screening


Accelerating Cancer Screening (AxCS) funding supports health centers to increase equitable access to cancer screening and referral for care and treatment by enhancing education, case management, outreach, and other enabling services, in close partnership or coordination with National Cancer Institute (NCI)-designated Cancer Centers that will deploy outreach specialists and patient navigators for populations served by health centers.

On this page:


This funding supports President Biden's call to action on cancer screening and early detection as part of the Administration's Cancer Moonshot initiative to reduce the cancer death rate by at least 50% over the next 25 years and support families living with and surviving cancer.

Award recipients will use AxCS funds to achieve two objectives:

  1. Increase the number and percentage of patients screened for at least one of the following cancer types: cervical, breast, or colorectal.
  2. Increase the number of patients assisted with accessing appropriate follow-up care (e.g., diagnostic services, therapies, clinical trials) within 30 days of receiving an abnormal cancer screening test result.

AxCS funding will support activities in the following areas:

  • Access and affordability;
  • Patient experience;
  • Screening; and 
  • Workforce development.

Progress Reporting

HRSA requires award recipients to submit periodic progress reports as well as a final report.

Reporting periods and due dates for the award (activity code: H8I):

FY 2023 Award Recipients

Report Reporting Period Available in EHBs Due Date
1 February 1, 2023 to 

July 31, 2023
August 1, 2023 August 15, 2023
2 August 1, 2023 to 

January 31, 2024
February 1, 2024 February 15, 2024
3 February 1, 2024 to 

July 31, 2024
August 1, 2024 August 15, 2024
Final February 1, 2023 to 

January 31, 2025
January 31, 2025 May 1, 2025

FY 2022 Award Recipients

Report Reporting Period Available in EHBs Due Date
1 September 1, 2022 to 

February 28, 2023
March 1, 2023 March 15, 2023
2 March 1, 2023 to 

August 31, 2023
September 1, 2023 September 15, 2023
3 September 1, 2023 to 

February 28, 2024
March 1, 2024 March 15, 2024
Final September 1, 2022 to 

August 31, 2024
August 31, 2024 November 29, 2024


Award Recipients

Frequently Asked Questions (FAQ)

Cancer Resources

Application Aids

Attachments and Forms

Technical Assistance


Program Questions

Email the Project Officer listed on your Notice of Award or complete the BPHC Contact Form:

  • Under Funding, select Supplemental Grant Award (e.g. COVID/ARP, PCHP, Capital)
  • Select Accelerating Cancer Screening (AxCS) supplemental grant award
  • Tell us about your request

Budget Questions

Email the Grants Management Specialist listed on your Notice of Award.

EHBs Health Center Program Support

Complete the BPHC Contact Form:

  • Under Technical Support, select EHBs Tasks/EHBs Technical Issues
  • Tell us about your request

Call 877-464-4772 (select option 1) 8 a.m. – 8 p.m. ET, Monday – Friday (except federal holidays).


Date Last Reviewed: